AuthorNeuzil, Kathleen M
Clemens, John D
Gordon, Melita A
Patel, Priyanka D
Pollard, Andrew J
JournalClinical Infectious Diseases
PublisherOxford University Press
MetadataShow full item record
AbstractClinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine. © The Author(s) 2020.
Rights/Terms© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/13537